Text size :

ALS: ‘The Promise’, the Aisla marathon supporting research and hope returns

ADNKRONOS

November 17, 2026

(Adnkronos) –

Bringing scientific discussion out of laboratories, making it understandable and accessible, without fueling illusions and without giving up hope. This is the objective of the national event ‘The Promise – For ALS Research’, promoted by the Italian Association of Amyotrophic Lateral Sclerosis (Aisla) scheduled in Rome, Wednesday, November 18, from 7 PM to 10 PM, at Palazzo dell’Informazione, and broadcast live streaming on Aisla and Adnkronos channels, media partners.

The live marathon, where music, entertainment, and life testimonies intertwine to support research on the disease, sees the participation of researchers, clinicians, people with ALS, families, and protagonists from the cultural and social world. Among the most anticipated moments is the discussion on precision medicine and scientific collaboration between Italy and the United States, which also arose from a question from an Italian family, that of Matteo Materazzi and Maura Soldati. In a preview, a contribution from Neil Shneider, director of the Eleanor and Lou Gehrig ALS Center at Columbia University in New York, will introduce the public to the prospects of research on targeted therapies for specific genetic forms of ALS. Along with American researchers, Italian clinicians involved in the international collaboration path will intervene. The discussion, led by Fabio Insenga, deputy director of Adnkronos, will give voice to the most pressing questions from people with ALS and their families. Those who wish to contribute can send their questions through Aisla’s official Facebook page, in the comments to the dedicated post, or participate in the event in person, after free registration on Eventbrite.

 

The appointment is for Wednesday, November 18, 2026, from 7 PM to 10 PM, at Palazzo dell’Informazione – Rome and live streamed on Aisla and Adnkronos channels.

Live streaming on Youtube: https://youtube.com/live/2A8-1TUdHNo?feature=share

Jiji Press

Related

Page TOP